Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Helsinki - Delayed Quote EUR

BBS-Bioactive Bone Substitutes Oyj (BONEH.HE)

0.0538
0.0000
(0.00%)
At close: February 12 at 2:09:46 PM GMT+2

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Juliusz Rakowskias Chief Executive Officer -- -- --
Annastiina Kauppinen Financial manager -- -- --
Mr. Paul C. Watkins Chief Commercial Officer & Member of Advisory Board -- -- --

BBS-Bioactive Bone Substitutes Oyj

Kiviharjunlenkki 6
Oulu, 90220
Finland
358 4070 80307 https://www.bbs-artebone.fi
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
24

Description

BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. It offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. The company was incorporated in 1991 and is headquartered in Oulu, Finland.

Corporate Governance

BBS-Bioactive Bone Substitutes Oyj’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers